93 related articles for article (PubMed ID: 3612685)
1. Aromatase inhibition by 5-substituted pyrimidines and dihydropyrimidines.
Taylor HM; Jones CD; Davenport JD; Hirsch KS; Kress TJ; Weaver D
J Med Chem; 1987 Aug; 30(8):1359-65. PubMed ID: 3612685
[TBL] [Abstract][Full Text] [Related]
2. Estrogen synthetase inhibitors. 2. Comparison of the in vitro aromatase inhibitory activity for a variety of nitrogen heterocycles substituted with diarylmethane or diarylmethanol groups.
Jones CD; Winter MA; Hirsch KS; Stamm N; Taylor HM; Holden HE; Davenport JD; Krumkalns EV; Suhr RG
J Med Chem; 1990 Jan; 33(1):416-29. PubMed ID: 2296032
[TBL] [Abstract][Full Text] [Related]
3. Studies on aromatase inhibitors. IV. Synthesis and biological evaluation of N,N-disubstituted-5-aminopyrimidine derivatives.
Okada M; Yoden T; Kawaminami E; Shimada Y; Kudoh M; Isomura Y
Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1293-9. PubMed ID: 9301028
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives.
Marsh DA; Brodie HJ; Garrett W; Tsai-Morris CH; Brodie AM
J Med Chem; 1985 Jun; 28(6):788-95. PubMed ID: 4009601
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of estrogen derivatives as aromatase inhibitors. Effects of heterocyclic substituents.
Numazawa M; Komatsu S; Tominaga T; Yamashita K
Chem Pharm Bull (Tokyo); 2008 Sep; 56(9):1304-9. PubMed ID: 18758106
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors.
Li PK; Brueggemeier RW
J Med Chem; 1990 Jan; 33(1):101-5. PubMed ID: 2296006
[TBL] [Abstract][Full Text] [Related]
7. Detection of aromatase inhibitors in vitro using rat ovary microsomes.
Odum J; Ashby J
Toxicol Lett; 2002 Mar; 129(1-2):119-22. PubMed ID: 11879982
[TBL] [Abstract][Full Text] [Related]
8. Studies on aromatase inhibitors. I. Synthesis and biological evaluation of 4-amino-4H-1,2,4-triazole derivatives.
Okada M; Yoden T; Kawaminami E; Shimada Y; Kudoh M; Isomura Y; Shikama H; Fujikura T
Chem Pharm Bull (Tokyo); 1996 Oct; 44(10):1871-9. PubMed ID: 8904814
[TBL] [Abstract][Full Text] [Related]
9. Discovery and development of a novel class of nonsteroidal aromatase inhibitors.
Hirsch KS; Jones CD; Lindstrom TD; Stamm NB; Sutton GP; Taylor HM; Weaver DE
Steroids; 1987; 50(1-3):201-17. PubMed ID: 3504060
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
Kellis JT; Vickery LE
Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of rainbow trout (Oncorhynchus mykiss) P450 aromatase activities in brain and ovarian microsomes by various environmental substances.
Hinfray N; Porcher JM; Brion F
Comp Biochem Physiol C Toxicol Pharmacol; 2006 Nov; 144(3):252-62. PubMed ID: 17081805
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and endocrine properties of a mechanism-based inhibitor of aromatase.
Johnston JO; Wright CL; Metcalf BW
Endocrinology; 1984 Aug; 115(2):776-85. PubMed ID: 6745181
[TBL] [Abstract][Full Text] [Related]
13. Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.
Su B; Hackett JC; Díaz-Cruz ES; Kim YW; Brueggemeier RW
Bioorg Med Chem; 2005 Dec; 13(23):6571-7. PubMed ID: 16125392
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of benzimidazolyl-1,3,5-triazine and benzimidazolylpyrimidine derivatives.
Matsuno T; Karo M; Sasahara H; Watanabe T; Inaba M; Takahashi M; Yaguchi SI; Yoshioka K; Sakato M; Kawashima S
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1778-81. PubMed ID: 11086914
[TBL] [Abstract][Full Text] [Related]
15. 7 alpha-substituted derivatives of androstenedione as inhibitors of estrogen biosynthesis.
Darby MV; Lovett JA; Brueggemeier RW; Groziak MP; Counsell RE
J Med Chem; 1985 Jun; 28(6):803-7. PubMed ID: 4009603
[TBL] [Abstract][Full Text] [Related]
16. Substituted C19 steroid analogs as inhibitors of aromatase.
Brueggemeier RW; Snider CE; Counsell RE
Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
[TBL] [Abstract][Full Text] [Related]
17. Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.
Atwal KS; Rovnyak GC; Kimball SD; Floyd DM; Moreland S; Swanson BN; Gougoutas JZ; Schwartz J; Smillie KM; Malley MF
J Med Chem; 1990 Sep; 33(9):2629-35. PubMed ID: 2391701
[TBL] [Abstract][Full Text] [Related]
18. 1-[(Benzofuran-2-yl)phenylmethyl]triazoles as steroidogenic inhibitors: synthesis and in vitro inhibition of human placental CYP19 aromatase.
Vinh TK; Yee SW; Kirby AJ; Nicholls PJ; Simons C
Anticancer Drug Des; 2001; 16(4-5):217-25. PubMed ID: 12049480
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts--a comparative study.
van Meeuwen JA; Nijmeijer S; Mutarapat T; Ruchirawat S; de Jong PC; Piersma AH; van den Berg M
Toxicol Appl Pharmacol; 2008 May; 228(3):269-76. PubMed ID: 18201740
[TBL] [Abstract][Full Text] [Related]
20. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
Marcotte PA; Robinson CH
Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
